Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene.
暂无分享,去创建一个
M. Kazatchkine | F. Mbopi-Kéou | F. Clavel | L. Bélec | L. Andréoletti | J. Malkin | L. Weiss | T. Prazuck | C. Piketty | A. Si‐Mohamed | M. Matta | G. Calamy
[1] E. De Clercq,et al. Prevalence and Characteristics of Multinucleoside-Resistant Human Immunodeficiency Virus Type 1 among European Patients Receiving Combinations of Nucleoside Analogues , 2000, Antimicrobial Agents and Chemotherapy.
[2] S. Paulous,et al. Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies. , 1999, AIDS.
[3] D. Stuart,et al. A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog Resistance , 1999, Antimicrobial Agents and Chemotherapy.
[4] M. Hillebrand,et al. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. , 1999, AIDS.
[5] D. Katzenstein,et al. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. , 1998, The Journal of clinical investigation.
[6] Franqois,et al. Genetic recombination of human immunodeficiency virus , 1989, Journal of virology.
[7] C. Katlama,et al. Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis. , 1992, Journal of acquired immune deficiency syndromes.